Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ACAD
#1540
Acadia Pharmaceuticals Inc.
21.9
3
USD
+2.19%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+2.19%
Monthly Change
+4.33%
6 month change
+7.45%
Year Change
+47.58%
Previous Close
21.4
6
Open
21.9
3
Bid
Ask
Low
21.8
7
High
22.0
4
Volume
419
Markets
US Stock Market
Healthcare
ACAD
Open full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
160.05 M
161.2 M
162.23 M
164.77 M
166.79 M
170.49 M
—
Valuation ratios
Enterprise value
8.23 B
3.62 B
2.53 B
4.9 B
2.74 B
4.38 B
13.68 B
Price to earnings ratio
—
—
-12.18
-83.41
13.49
11.61
53.72
Price to sales ratio
—
—
0.01
0.01
3.19
4.24
13.98
Price to cash flow ratio
—
—
-0.02
0.3
19.36
41.32
97.18
Price to book ratio
—
—
0.01
0.01
4.17
3.7
7.12
Enterprise value to EBITDA ratio
-30.14
-22.95
-11.29
-61.62
7.43
43.65
155.34
Profitability ratios
Return on assets %
-0.36
-0.24
-0.37
-0.08
0.19
0.25
0.27
Return on equity %
-0.45
-0.31
-0.54
-0.14
0.31
0.32
0.36
Return on invested capital %
-2 612.98
-927.62
-1 116.07
-331.41
423.81
314.06
333.1
Gross margin %
97.69
97.76
98.03
94.27
91.46
91.69
366.81
Operating margin %
-64.87
-35.2
-43.23
-10.1
24.1
9.78
39.09
EBITDA margin %
-61.81
-32.53
-43.37
-10.94
38.52
9.36
37.34
Net margin %
-63.74
-34.67
-41.76
-8.44
23.64
36.49
139.94
Liquidity ratios
Quick ratio
6.68
6.28
3.95
2.26
2.14
3.43
11.27
Current ratio
6.77
6.43
4.04
2.42
2.38
3.83
12.64
Inventory turnover
1.27
0.91
0.79
1.6
1.24
0.88
0.85
Asset turnover
0.56
0.65
0.8
1.09
0.99
0.78
0.85
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
—
—
-705.3
101.95
0.95
0.65
0.65
EBIT per share
—
—
-1 382.93
-447.93
1.39
0.62
0.62
EBITDA per share
—
—
-1 387.32
-485
2.22
0.59
0.59
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
—
2 578.03
2 678.96
4.54
4.82
18.37
Net current asset value per share
—
—
3 141.56
3 761.01
5.64
6.25
23.45
Tangible book value per share
—
—
2 476.53
2 235.79
3.68
6.58
19.37
Working capital per share
—
—
2 364.55
2 208.97
3.27
4.62
15.97
Book value per share
—
—
2 476.53
2 635.56
4.4
7.22
22.04
ACADIA Pharmaceuticals Inc
Acadia Pharmaceuticals Inc. is a biopharmaceutical company headquartered in Del Mar, San Diego, California.
News
Will Acadia (ACAD) Beat Estimates Again in Its Next Earnings Report?
Biotech Is Holding Steady In 2026 (NASDAQ:IBB)
Why Is Acadia (ACAD) Down 12.9% Since Last Earnings Report?
Tracking Baker Brothers Portfolio – Q4 2025 Update (NASDAQ:INCY)
AXSM's 2025 Revenue Surge Largely Driven by Auvelity: What's Ahead?
JAZZ or ACAD: Which Is the Better Value Stock Right Now?
Acadia Pharmaceuticals appoints Jonathan M. Poole to board of directors
ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU (Revised)
ACAD Plans Re-Examination After CHMP Rejects Rett Syndrome Drug in EU
BofA cuts Acadia Pharmaceuticals price target on pipeline review
BofA cuts Acadia Pharmaceuticals stock price target on EU setback
Acadia receives negative EU opinion for Rett syndrome drug